Vol. 23 No. 5 (2025): Blood Transfusion 5-2025 (September-October)
Full Issue
Requires Subscription
pdf
Editorial
Review
-
When is ABO-incompatible plasma safe to transfuse? Defining an empirical estimation of anti-A/anti-B in ABO incompatible plasma-containing blood products: Transfusion of ABO-incompatible plasma
-
The Red Blood Cell-Improving Transfusions for Chronically Transfused Recipients (RBC-IMPACT) study: protocol description of an international multi-site observational clinical study: RBC-IMPACT protocol description
-
Chimeric antigen receptor therapy for hematological malignancies: a pediatric perspective from leukapheresis to infusion: CAR T cell therapy for pediatric hematologic malignancies
Original article
-
Molecular characterization of variant D antigen expression among 56,445 blood donors in East India: RHD variants in East India
-
Pilot study of ABO-isogroup or universal plasma pools with or without pathogen reduction treatment: Pathogen reduced plasmas from maxi-pools
-
Effectiveness of oral platelet lysate gel to treat oral mucosal manifestations associated with chronic graft versus host disease: PL gel for oral cGvHD: efficacy and safety